SCHEMBL19794398

SCHEMBL19794398

c1ccc(-c2cc(-c3ccccc3-c3ccc(-c4nc5ccccc5[nH]4)cc3)cc(-c3ccccc3-c3ccc(-c4nc5ccccc5[nH]4)cc3)c2)c(-c2ccc(-c3nc4ccccc4[nH]3)cc2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 13/20 0.68
▸ RAB9A P51151 13/20 0.68
▸ GAA P10253 2/20 0.68
▸ ALDH1A1 P00352 13/20 0.65
▸ KDM4E B2RXH2 11/20 0.65
▸ SMN1; SMN2 Q16637 11/20 0.65
▸ HPGD P15428 7/20 0.65
▸ HSD17B10 Q99714 5/20 0.65
▸ MAPT P10636 5/20 0.65
▸ TP53 P04637 3/20 0.65
▸ POLB P06746 2/20 0.65
▸ GFER P55789 1/20 0.65
▸ PKN1 Q16512 1/20 0.62
▸ PKN2 Q16513 1/20 0.62
▸ PKM P14618 5/20 0.60
▸ NPSR1 Q6W5P4 3/20 0.60
▸ ABCB11 O95342 1/20 0.60
▸ HDAC6 Q9UBN7 1/20 0.59
▸ USP2 O75604 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29386825 0.87 NPC1 (0.88) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL2178266 0.87 NPC1 (0.88) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL12153689 0.85 NPC1 (0.77) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL24295036 0.85 NPC1 (0.84) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL29306762 0.84 SMN1; SMN2 (0.62) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL22499602 0.83 NPC1 (0.81) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL15497747 0.83 NPC1 (0.74) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL27806611 0.83 RAB9A (0.68) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL29927066 0.82 RAB9A (0.72) NPC1RAB9AGAAALDH1A1KDM4E
SCHEMBL28415845 0.82 RAB9A (0.72) NPC1RAB9AGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 — — US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 — — EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC NPC1 4039/4885RAB9A 2171/4885GAA 3285/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 NPC1 2761/4885RAB9A 1433/4885GAA 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback